New one-dose treatment edits a gene in the liver, disabling the ANGPTL3 protein and significantly lowers cholesterol.

How weight loss and diet changes show up in lab results Weight loss creates measurable improvements in lab work that doctors track regularly throughout your journey.

Researchers developed TLC-2716, a liver- and gut-targeted drug that selectively reduced LXR activity, lowering triglycerides, ...

I reassured him and sent him to get another blood specimen drawn without a tourniquet. Why? Because I suspected that the ...

A study shows that some non-alcoholic beers can raise blood sugar and fat levels in just four weeks, according to recent ...

Scientists have found a way to fine-tune a central fat-control pathway in the liver, reducing harmful blood triglycerides ...

January always carries a certain energy. Even if we aren’t trying to overhaul everything at once, there is still this ...

When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.

In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...

In A Nutshell The small, short trial showed no serious side effects, but much larger and longer studies are needed to prove ...

The Qatar Press Centre (QPC) has signed a partnership agreement with Al Riyada Medical Centre aimed at providing distinguished ...